Ambrisentan
Inquiry
| Post Date: | Sep 29,2014 |
| Expiry Date: | Mar 28,2015 |
| Detailed Description: | Cas No. :177036-94-1 Pulmonary Hypertension Drug |
| CAS Registry Number: | 177036-94-1 |
| Synonyms: | ;Bsf 208075,(+)-(2S)-2-[(4,6-Dimethylpyrimidin-2-Yl)Oxy]-3-Methoxy-3,3-Diphenylpropanoic Acid;2-(4,6-Dimethylpyrimidin-2-Yl)Oxy-3-Methoxy-3,3-Di(Phenyl)Propanoic Acid;(As)-A-[(4,6-Dimethyl-2-Pyrimidinyl)Oxy]--Methoxy--Phenylbenzenepropanoic Acid;Bsf 208075;Lu 208075;(2S)-2-[(4,6-Dimethylpyrimidin-2-Yl)Oxy]-3-Methoxy-3,3-Diphenylpropanoic Acid; |
| Molecular Formula: | C22H22N2O4 |
| Molecular Weight: | 378.4211 |
| Molecular Structure: | 
|
| Company: | Lianyungang Guike Pharmaceutical Co.,ltd |
| Contact: | Sophia |
| Tel: | 0518-86070856 |
| Fax: | 0518-86070852 |
| Email: | sophia@guikepharm.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
